Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1681 to 1695 of 8314 results

  1. Epilepsies in children, young people and adults (extraordinary review)

    In development Reference number: GID-NG10378 Expected publication date: TBC

  2. Bipolar disorder: assessment and management (extraordinary review)

    In development Reference number: GID-NG10380 Expected publication date: TBC

  3. Abdominal aortic aneurysm

    Awaiting development Reference number: GID-QS10035 Expected publication date: TBC

  4. Acne

    Awaiting development Reference number: GID-QS10036 Expected publication date: TBC

  5. Adrenal dysfunction

    Awaiting development Reference number: GID-QS10038 Expected publication date: TBC

  6. Pancreatitis (including acute pancreatitis)

    Awaiting development Reference number: GID-QS10085 Expected publication date: TBC

  7. Diverticular disease

    Awaiting development Reference number: GID-QS10086 Expected publication date: TBC

  8. Thyroid disease

    Awaiting development Reference number: GID-QS10088 Expected publication date: TBC

  9. Tinnitus

    Awaiting development Reference number: GID-QS10091 Expected publication date: TBC

  10. Pain management (young people and adults)

    Awaiting development Reference number: GID-QS10093 Expected publication date: TBC

  11. Shared decision-making: practical guidance for health and social care professionals

    Awaiting development Reference number: GID-QS10097 Expected publication date: TBC

  12. Gout

    Awaiting development Reference number: GID-QS10100 Expected publication date: TBC

  13. Heart valve disease in adults

    Awaiting development Reference number: GID-QS10101 Expected publication date: TBC

  14. Veliparib with carboplatin and paclitaxel for untreated non-squamous non-small-cell lung cancer [ID1277]

    In development Reference number: GID-TA10248 Expected publication date: TBC

  15. Talacotuzumab for untreated acute myeloid leukaemia [ID1262]

    In development Reference number: GID-TA10249 Expected publication date: TBC